Investor Relations

Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Obtaining Drug Registration Certificate for Acetylcysteine Solution for Inhalation

Time:2022-10-14

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on the Company's Drugs Approved for Registration in Indonesia

Time:2022-09-27